WEST PHILADELPHIA (WPVI) -- Business and life partners Sasha Vivek and Britt Gilbert recently opened a unique space in West Philadelphia offering light bites and authentic chai. The cafe aspect of ...

DC now has more exceptional Indian restaurants than great steakhouses, so it felt almost excessive when Meherwan Irani and Vishwesh Bhatt announced this northernmost outpost of Irani’s James Beard ...

Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process. Traditional techniques, like high-throughput screening, offer an ...

Chai Discovery’s AI platform, including purpose-built custom models, will be deployed to accelerate the discovery of next-generation therapeutics SAN FRANCISCO--(BUSINESS WIRE)--Chai Discovery, the AI ...

Following Tropical Storm Helene, Chai Pani introduced a “hurricane hot bar” for a month that ended last March. The buffet served comfort food to guests and kept the restaurant’s staff employed amid ...

Hot chai and scrupulously spiced Desi street food are the specialty at a new eatery in Concord. Chai & Co. opened in late November at 2115 Pacheco St., near Todos Santos Plaza, in the former spot of ...

Chai Discovery, a biotech startup with backing from OpenAI, announced a $130 million Series B round at a $1.3 billion valuation on Monday. The round was led by General Catalyst and Oak HC/FT, the ...

Chai Discovery Inc., a startup using artificial intelligence to accelerate drug development, today announced that it has closed a $130 million funding round led by Oak HC/FT and General Catalyst. The ...

OpenAI-backed biotech startup Chai Discovery has raised $130 million in a Series B funding round, pushing its valuation to $1.3 billion. With the Series B funding, Chai's total capital raised exceeds ...

Josh Meier, CEO of Chai Discovery, said his startup’s models are improving at a rapid rate. Courtesy Chai Discovery Chai Discovery, a San Francisco-based startup backed by OpenAI, is the latest drug ...

Chai Discovery, an artificial intelligence drug-discovery company backed by OpenAI, has raised $130 million to build a “computer-aided design suite” for molecules. The deal, which values the company ...